Bayer CropScience opens new Mustard Breeding Station in India
Mumbai, February 04, 2013 – The Seeds Business unit of Bayer CropScience India has inaugurated a new Breeding Station in Palwal, Haryana. Its mission is to develop new varieties of Indian Mustard (Brassica juncea), which is closely related to Canola/Rapeseed (Brassica napus).
Bayer CropScience is the global market leader in Canola Hybrid Seeds, with around 25% global market share. This makes Indian Mustard a strategic crop for Bayer. India has approximately 6.5 million hectares under mustard cultivation. Of late, the commercial mustard seed market in India is growing with improved seed replacement rates and an increasing number of farmers inclining towards high yielding commercial seeds. The new station will focus on breeding and development of core germplasm for high performing Mustard Hybrids for both Indian and global markets.
The breeding station will be spread across ten acres of land and will house labs, an administrative building and plots for breeding development. Eight employees stationed at the site will work on developing key trait and breeding targets in the fields of yield assurance through herbicide tolerance; disease control; yield enhancement; seed shatter resistance and oil quality.
The research block will have a state-of-the-art pathological laboratory with growth chambers to screen strains and hybrids for disease tolerance. The oil and meal quality laboratory will facilitate in-house estimation of fatty acid profile of oil, oil content and protein composition of meal to serve specific nutritional benefits or industrial uses. The station will also have seed cleaning and seed preparation laboratories, a cold room for germplasm storage and spare labs for future expansion activities, including doubled haploidy and molecular breeding.
Joerg Rehbein, Head of Bayer CropScience, Indian Subcontinent; Satish Patil, Country Head – Seeds & Traits, Bayer CropScience India and Rick Turner, Global Market Head Wheat & Oilseeds, Bayer CropScience, inaugurated the Mustard Breeding Station in Palwal on February 1, 2013.
Rape, canola or mustard offer valuable protein as food and feed and are also a source of high-quality vegetable oil for human consumption, for industrial lubricants and for biodiesel. Bayer CropScience’s main biotech research center for oilseeds is located in Ghent (Belgium). Besides India, the company’s key breeding stations are located in Canada, Europe and Australia.
About Bayer CropScience
Bayer is a global enterprise with core competencies in the fields of health care, agriculture and high-tech materials. This year the company looks back on 150 years of working to fulfill its mission “Bayer: Science For A Better Life”. Bayer CropScience, the subgroup of Bayer AG responsible for the agricultural business, has annual sales of EUR 7.255 billion (2011) and is one of the world’s leading innovative crop science companies in the areas of seeds, crop protection and non-agricultural pest control. The company offers an outstanding range of products including high value seeds, innovative crop protection solutions based on chemical and biological modes of action as well as an extensive service backup for modern, sustainable agriculture. In the area of non-agricultural applications, Bayer CropScience has a broad portfolio of products and services to control pests from home and garden to forestry applications. The company has a global workforce of 21,000 and is represented in more than 120 countries. This and further news is available at: www.press.bayercropscience.com.
Bayer Group in India
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.